Effect of some vasoactive peptides on the lower esophageal sphincter.
D000804:Angiotensin II / Q000494:pharmacology; D000818:Animals; D001920:Bradykinin / Q000494:pharmacology; D004943:Esophagogastric Junction / Q000187:drug effects*; D005260:Female; D006168:Guinea Pigs; D066298:In Vitro Techniques; D008297:Male; D009119:Muscle Contraction / Q000187:drug effects; D009130:Muscle, Smooth / Q000187:drug effects; D009496:Neurotensin / Q000494:pharmacology; D010455:Peptides / Q000494:pharmacology*; D051381:Rats; D013373:Substance P / Q000494:pharmacology; D014667:Vasopressins / Q000494:pharmacology
D010455:Peptides; D014667:Vasopressins; D000804:Angiotensin II; D013373:Substance P; D009496:Neurotensin; D001920:Bradykinin